William Blair analyst Matt Phipps reiterated an Outperform rating on Autolus Therapeutics plc (NASDAQ: AUTL)The analyst commented, "Autolus shares are ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments